Mimedx (MDXG) Depreciation & Amortization (CF) (2024 - 2026)

Mimedx has disclosed Depreciation & Amortization (CF) across 3 years of filings, most recently posting $1.5 million for Q2 2026.

• In Q2 2026, Depreciation & Amortization (CF) fell 51.67% year-over-year to $1.5 million; the TTM figure through Jun 2026 stood at $11.7 million (up 10.86% YoY), while the FY2025 annual figure was $14.9 million, up 146.33% from the prior year.
• Depreciation & Amortization (CF) came in at $1.5 million for Q2 2026 at Mimedx, down from $1.6 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $5.3 million in Q3 2025 to a low of $1.2 million in Q3 2024.
• Average Depreciation & Amortization (CF) over 3 years is $2.8 million, with a median of $3.1 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) jumped 358.01% in 2025 and sank 51.67% in 2026.
• Over 3 years, Depreciation & Amortization (CF) stood at $3.0 million in 2024, then grew by 7.69% to $3.2 million in 2025, then slumped by 52.45% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.5 million in Q2 2026, $1.6 million in Q1 2026, and $3.2 million in Q4 2025.